Tuttle et al. Phase 2 RCT of Peresolimab (PD-1 stimulator) in DMARD-IR RA. Evidence of efficacy. No new safety signals @RheumNow #ACR22 Abstr#L03
A Phase 2 Trial of Peresolimab for Adults with Rheumatoid Arthritis - ACR Meeting Abstracts
